Download PDF
Thorac Cardiovasc Surg 2018; 66(04): 278-286
DOI: 10.1055/s-0036-1583525
Review Article
Georg Thieme Verlag KG Stuttgart · New York

The Value of Circulating Biomarkers in Bicuspid Aortic Valve-Associated Aortopathy

Shiho Naito
1   Department of Cardiac Surgery, Central Hospital Bad Berka, Bad Berka, Germany
,
Mathias Hillebrand
2   Department of Cardiology, University Heart Center Hamburg, Hamburg, Germany
,
Alexander Martin Justus Bernhardt
3   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
,
Annika Jagodzinski
2   Department of Cardiology, University Heart Center Hamburg, Hamburg, Germany
,
Lenard Conradi
3   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
,
Christian Detter
3   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
,
Karsten Sydow
2   Department of Cardiology, University Heart Center Hamburg, Hamburg, Germany
,
Hermann Reichenspurner
3   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
,
Yskert von Kodolitsch
2   Department of Cardiology, University Heart Center Hamburg, Hamburg, Germany
,
Evaldas Girdauskas
3   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
› Author Affiliations
Further Information

Publication History

06 January 2016

14 March 2016

Publication Date:
05 May 2016 (online)

    Permissions and Reprints All articles of this category

Abstract

Traditional risk stratification model of bicuspid aortic valve (BAV) aortopathy is based on measurement of maximal cross-sectional aortic diameter, definition of proximal aortic shape, and aortic stiffness/elasticity parameters. However, conventional imaging-based criteria are unable to provide reliable information regarding the risk stratification in BAV aortopathy, especially considering the heterogeneous nature of BAV disease. Given those limitations of conventional imaging, there is a growing clinical interest to use circulating biomarkers in the screening process for thoracic aortic aneurysms as well as in the risk-assessment algorithms. We aimed to systematically review currently available biomarkers, which may be of value to predict the natural evolution of aortopathy in individuals with BAV.

Keywords

bicuspid aortic valve - aortopathy - biomarkers
 

  • References

  • 1 Basso C, Boschello M, Perrone C. , et al. An echocardiographic survey of primary school children for bicuspid aortic valve. Am J Cardiol 2004; 93 (05) 661-663
    CrossrefPubMedSearch in Google Scholar
  • 2 Nistri S, Basso C, Marzari C, Mormino P, Thiene G. Frequency of bicuspid aortic valve in young male conscripts by echocardiogram. Am J Cardiol 2005; 96 (05) 718-721
    CrossrefPubMedSearch in Google Scholar
  • 3 Panayotova R, Macnab A, Waterworth PD. A pilot project of familial screening in patients with bicuspid aortic valve disease. J Heart Valve Dis 2013; 22 (02) 150-155
    PubMedSearch in Google Scholar
  • 4 Tutar E, Ekici F, Atalay S, Nacar N. The prevalence of bicuspid aortic valve in newborns by echocardiographic screening. Am Heart J 2005; 150 (03) 513-515
    CrossrefPubMedSearch in Google Scholar
  • 5 Fedak PWM, Verma S, David TE, Leask RL, Weisel RD, Butany J. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002; 106 (08) 900-904
    CrossrefPubMedSearch in Google Scholar
  • 6 Girdauskas E, Borger MA, Secknus M-A, Girdauskas G, Kuntze T. Is aortopathy in bicuspid aortic valve disease a congenital defect or a result of abnormal hemodynamics? A critical reappraisal of a one-sided argument. Eur J Cardiothorac Surg 2011; 39 (06) 809-814
    CrossrefPubMedSearch in Google Scholar
  • 7 Hiratzka LF, Bakris GL, Beckman JA. , et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American College of Radiology; American Stroke Association; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of Thoracic Surgeons; Society for Vascular Medicine. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121 (13) e266-e369
    CrossrefPubMedSearch in Google Scholar
  • 8 Erbel R, Aboyans V, Boileau C. , et al; ESC Committee for Practice Guidelines; The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. Eur Heart J 2014; 35 (41) 2873-2926
    CrossrefPubMedSearch in Google Scholar
  • 9 Svensson LG, Adams DH, Bonow RO. , et al. Aortic valve and ascending aorta guidelines for management and quality measures. Ann Thorac Surg 2013; 95 (6, Suppl): S1-S66
    CrossrefPubMedSearch in Google Scholar
  • 10 von Kodolitsch Y, Robinson P, Berger J. When should surgery be performed in Marfan syndrome and other connective tissue disorders to protect against type a dissection?. In: Bonser RS, Pagano D, Haverich A, Mascaro J. eds. Controversies in Aortic Dissection and Aneurysmal Disease. London: Springer; 2014: 17-47
    Search in Google Scholar
  • 11 Charitos EI, Stierle U, Petersen M. , et al. The fate of the bicuspid valve aortopathy after aortic valve replacement. Eur J Cardiothorac Surg 2014; 45 (05) e128-e135
    Search in Google Scholar
  • 12 Itagaki S, Chikwe JP, Chiang YP, Egorova NN, Adams DH. Long-term risk for aortic complications after aortic valve replacement in patients with bicuspid aortic valve versus Marfan syndrome. J Am Coll Cardiol 2015; 65 (22) 2363-2369
    CrossrefPubMedSearch in Google Scholar
  • 13 Pape LA, Tsai TT, Isselbacher EM. , et al; International Registry of Acute Aortic Dissection (IRAD) Investigators. Aortic diameter >or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation 2007; 116 (10) 1120-1127
    CrossrefPubMedSearch in Google Scholar
  • 14 von Kodolitsch Y, Rybczynski M, Bernhardt A. , et al. Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: do we need genetics for clinical decisions?. Vasa 2010; 39 (01) 17-32
    CrossrefPubMedSearch in Google Scholar
  • 15 Borger MA, Preston M, Ivanov J. , et al. Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease?. J Thorac Cardiovasc Surg 2004; 128 (05) 677-683
    Search in Google Scholar
  • 16 Della Corte A, Bancone C, Dialetto G. , et al. The ascending aorta with bicuspid aortic valve: a phenotypic classification with potential prognostic significance. Eur J Cardiothorac Surg 2014; 46 (02) 240-247 , discussion 247
    CrossrefPubMedSearch in Google Scholar
  • 17 Nistri S, Grande-Allen J, Noale M. , et al. Aortic elasticity and size in bicuspid aortic valve syndrome. Eur Heart J 2008; 29 (04) 472-479
    CrossrefPubMedSearch in Google Scholar
  • 18 Rylski B, Branchetti E, Bavaria JE. , et al. Modeling of predissection aortic size in acute type A dissection: more than 90% fail to meet the guidelines for elective ascending replacement. J Thorac Cardiovasc Surg 2014; 148 (03) 944-8.e1
    CrossrefPubMedSearch in Google Scholar
  • 19 Girdauskas E, Rouman M, Disha K. , et al. Aortic dissection after previous aortic valve replacement for bicuspid aortic valve disease. J Am Coll Cardiol 2015; 66 (12) 1409-1411
    CrossrefPubMedSearch in Google Scholar
  • 20 Della Corte A, Bancone C, Quarto C. , et al. Predictors of ascending aortic dilatation with bicuspid aortic valve: a wide spectrum of disease expression. Eur J Cardiothorac Surg 2007; 31 (03) 397-404 , discussion 404–405
    CrossrefPubMedSearch in Google Scholar
  • 21 Fazel SS, Mallidi HR, Lee RS. , et al. The aortopathy of bicuspid aortic valve disease has distinctive patterns and usually involves the transverse aortic arch. J Thorac Cardiovasc Surg 2008; 135 (04) 901-907 , 907.e1–907.e2
    Search in Google Scholar
  • 22 Schaefer BM, Lewin MB, Stout KK. , et al. The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape. Heart 2008; 94 (12) 1634-1638
    CrossrefPubMedSearch in Google Scholar
  • 23 Park CB, Greason KL, Suri RM, Michelena HI, Schaff HV, Sundt III TM. Fate of nonreplaced sinuses of Valsalva in bicuspid aortic valve disease. J Thorac Cardiovasc Surg 2011; 142 (02) 278-284
    CrossrefPubMedSearch in Google Scholar
  • 24 Mortensen K, Aydin MA, Rybczynski M. , et al. Augmentation index relates to progression of aortic disease in adults with Marfan syndrome. Am J Hypertens 2009; 22 (09) 971-979
    CrossrefPubMedSearch in Google Scholar
  • 25 Shim CY, Cho IJ, Yang WI. , et al. Central aortic stiffness and its association with ascending aorta dilation in subjects with a bicuspid aortic valve. J Am Soc Echocardiogr 2011; 24 (08) 847-852
    CrossrefPubMedSearch in Google Scholar
  • 26 Aydin A, Desai N, Bernhardt AM. , et al. Ascending aortic aneurysm and aortic valve dysfunction in bicuspid aortic valve disease. Int J Cardiol 2013; 164 (03) 301-305
    CrossrefPubMedSearch in Google Scholar
  • 27 Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE, Sutton MG. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation 2000; 102 (19) (Suppl. 03) III35-III39
    CrossrefPubMedSearch in Google Scholar
  • 28 Hillebrand M, Koschyk D, ter Hark P. , et al. Sensitivity and specificity of routine echocardiography for bicuspid aortic valve disease: Retrospective study, systematic review and meta-analysis. in preparation
    PubMed
  • 29 Nejatian A, Yu J, Geva T, White MT, Prakash A. Aortic measurements in patients with aortopathy are larger and more reproducible by cardiac magnetic resonance compared with echocardiography. Pediatr Cardiol 2015; 36 (08) 1761-1773
    CrossrefPubMedSearch in Google Scholar
  • 30 Flachskampf FA, Badano L, Daniel WG. , et al; European Association of Echocardiography; Echo Committee of the European Association of Cardiothoracic Anaesthesiologists. Recommendations for transoesophageal echocardiography: update 2010. Eur J Echocardiogr 2010; 11 (07) 557-576
    CrossrefPubMedSearch in Google Scholar
  • 31 Suzuki T, Bossone E, Sawaki D. , et al. Biomarkers of aortic diseases. Am Heart J 2013; 165 (01) 15-25
    CrossrefPubMedSearch in Google Scholar
  • 32 Trimarchi S, Sangiorgi G, Sang X. , et al. In search of blood tests for thoracic aortic diseases. Ann Thorac Surg 2010; 90 (05) 1735-1742
    CrossrefPubMedSearch in Google Scholar
  • 33 Branchetti E, Bavaria JE, Grau JB. , et al. Circulating soluble receptor for advanced glycation end product identifies patients with bicuspid aortic valve and associated aortopathies. Arterioscler Thromb Vasc Biol 2014; 34 (10) 2349-2357
    CrossrefPubMedSearch in Google Scholar
  • 34 Drapisz S, Góralczyk T, Jamka-Miszalski T, Olszowska M, Undas A. Nonstenotic bicuspid aortic valve is associated with elevated plasma asymmetric dimethylarginine. J Cardiovasc Med (Hagerstown) 2013; 14 (06) 446-452
    CrossrefPubMedSearch in Google Scholar
  • 35 Ikonomidis JS, Ivey CR, Wheeler JB. , et al. Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease. J Thorac Cardiovasc Surg 2013; 145 (05) 1326-1333
    CrossrefPubMedSearch in Google Scholar
  • 36 Black KM, Masuzawa A, Hagberg RC. , et al. Preliminary biomarkers for identification of human ascending thoracic aortic aneurysm. J Am Heart Assoc 2013; 2 (06) e000138
    CrossrefPubMedSearch in Google Scholar
  • 37 Grewal N, Gittenberger-de Groot AC, DeRuiter MC. , et al. Bicuspid aortic valve: phosphorylation of c-Kit and downstream targets are prognostic for future aortopathy. Eur J Cardiothorac Surg 2014; 46 (05) 831-839
    CrossrefPubMedSearch in Google Scholar
  • 38 Apte SS, Parks WC. Metalloproteinases: a parade of functions in matrix biology and an outlook for the future. Matrix Biol 2015; 44–46: 1-6
    PubMedSearch in Google Scholar
  • 39 Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002; 110 (05) 625-632
    CrossrefPubMedSearch in Google Scholar
  • 40 McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999; 29 (01) 122-127 , discussion 127–129
    CrossrefPubMedSearch in Google Scholar
  • 41 Monaco M, Stassano P, Di Tommaso L, Iannelli G. Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2007; 134 (04) 925-931
    CrossrefPubMedSearch in Google Scholar
  • 42 Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 2004; 78 (06) 2106-2110 , discussion 2110–2111
    CrossrefPubMedSearch in Google Scholar
  • 43 Schmoker JD, McPartland KJ, Fellinger EK. , et al. Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2007; 133 (01) 155-161
    CrossrefPubMedSearch in Google Scholar
  • 44 Boyum J, Fellinger EK, Schmoker JD. , et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 2004; 127 (03) 686-691
    CrossrefPubMedSearch in Google Scholar
  • 45 Wang Y, Wu B, Dong L, Wang C, Wang X, Shu X. Circulating matrix metalloproteinase patterns in association with aortic dilatation in bicuspid aortic valve patients with isolated severe aortic stenosis. Heart Vessels 2016; 31 (02) 189-197
    CrossrefPubMedSearch in Google Scholar
  • 46 LeMaire SA, Wang X, Wilks JA. , et al. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res 2005; 123 (01) 40-48
    CrossrefPubMedSearch in Google Scholar
  • 47 Mohamed SA, Noack F, Schoellermann K. , et al. Elevation of matrix metalloproteinases in different areas of ascending aortic aneurysms in patients with bicuspid and tricuspid aortic valves. ScientificWorldJournal 2012; 2012: 806261
    PubMedSearch in Google Scholar
  • 48 Ikonomidis JS, Ruddy JM, Benton Jr SM. , et al. Aortic dilatation with bicuspid aortic valves: cusp fusion correlates to matrix metalloproteinases and inhibitors. Ann Thorac Surg 2012; 93 (02) 457-463
    CrossrefPubMedSearch in Google Scholar
  • 49 Rabkin SW. Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm - comparison with and without bicuspid aortic valve: a meta-analysis. Vasa 2014; 43 (06) 433-442
    CrossrefPubMedSearch in Google Scholar
  • 50 Tzemos N, Lyseggen E, Silversides C. , et al. Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta. J Am Coll Cardiol 2010; 55 (07) 660-668
    CrossrefPubMedSearch in Google Scholar
  • 51 Padang R, Bannon PG, Jeremy R. , et al. The genetic and molecular basis of bicuspid aortic valve associated thoracic aortopathy: a link to phenotype heterogeneity. Ann Cardiothorac Surg 2013; 2 (01) 83-91
    PubMedSearch in Google Scholar
  • 52 Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116 (02) 281-297
    CrossrefPubMedSearch in Google Scholar
  • 53 Boon RA, Dimmeler S. MicroRNAs and aneurysm formation. Trends Cardiovasc Med 2011; 21 (06) 172-177
    CrossrefPubMedSearch in Google Scholar
  • 54 Liu G, Huang Y, Lu X. , et al. Identification and characteristics of microRNAs with altered expression patterns in a rat model of abdominal aortic aneurysms. Tohoku J Exp Med 2010; 222 (03) 187-193
    CrossrefPubMedSearch in Google Scholar
  • 55 Elia L, Quintavalle M, Zhang J. , et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009; 16 (12) 1590-1598
    CrossrefPubMedSearch in Google Scholar
  • 56 Liao M, Zou S, Weng J. , et al. A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to thoracic aortic dissection pathogenesis. J Vasc Surg 2011; 53 (05) 1341-1349.e3
    CrossrefPubMedSearch in Google Scholar
  • 57 Jones JA, Stroud RE, O'Quinn EC. , et al. Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction. Circ Cardiovasc Genet 2011; 4 (06) 605-613
    CrossrefPubMedSearch in Google Scholar
  • 58 Boon RA, Seeger T, Heydt S. , et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 2011; 109 (10) 1115-1119
    CrossrefPubMedSearch in Google Scholar
  • 59 Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010; 121 (08) 1022-1032
    CrossrefPubMedSearch in Google Scholar
  • 60 Pannu H, Fadulu VT, Chang J. , et al. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 2005; 112 (04) 513-520
    CrossrefPubMedSearch in Google Scholar
  • 61 Matt P, Habashi J, Carrel T, Cameron DE, Van Eyk JE, Dietz HC. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?. J Thorac Cardiovasc Surg 2008; 135 (02) 389-394
    CrossrefPubMedSearch in Google Scholar
  • 62 Hillebrand M, Millot N, Sheikhzadeh S. , et al. Total serum transforming growth factor-β1 is elevated in the entire spectrum of genetic aortic syndromes. Clin Cardiol 2014; 37 (11) 672-679
    CrossrefPubMedSearch in Google Scholar
  • 63 Vignaud H, Cullin C, Bouchecareilh M. Alpha-1 antitrypsin deficiency: a model of alteration of protein homeostasis or proteostasis [in French]. Rev Mal Respir 2015; 32 (10) 1059-1071
    CrossrefPubMedSearch in Google Scholar
  • 64 Schachner T, Golderer G, Sarg B. , et al. The amounts of alpha 1 antitrypsin protein are reduced in the vascular wall of the acutely dissected human ascending aorta. Eur J Cardiothorac Surg 2010; 37 (03) 684-690
    CrossrefPubMedSearch in Google Scholar
  • 65 Kilickesmez KO, Abaci O, Kocas C. , et al. Dilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valve. Heart Vessels 2012; 27 (04) 391-397
    CrossrefPubMedSearch in Google Scholar
  • 66 Vizzardi E, Corda L, Pezzali N. , et al. Elastic properties of the ascending aorta in patients with α1-antitrypsin deficiency (Z homozygotes). Heart 2012; 98 (18) 1354-1358
    CrossrefPubMedSearch in Google Scholar
  • 67 Böger RH. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials. Vasc Med 2005; 10 (02) (Suppl. 01) S19-S25
    CrossrefPubMedSearch in Google Scholar
  • 68 Böger RH, Sullivan LM, Schwedhelm E. , et al. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 2009; 119 (12) 1592-1600
    CrossrefPubMedSearch in Google Scholar
  • 69 Schnabel R, Blankenberg S, Lubos E. , et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 2005; 97 (05) e53-e59
    CrossrefPubMedSearch in Google Scholar
  • 70 Hofmann MA, Drury S, Fu C. , et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97 (07) 889-901
    CrossrefPubMedSearch in Google Scholar
  • 71 Yan SD, Zhu H, Zhu A. , et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med 2000; 6 (06) 643-651
    CrossrefPubMedSearch in Google Scholar
  • 72 Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 2010; 106 (05) 842-853
    CrossrefPubMedSearch in Google Scholar
  • 73 Cuccurullo C, Iezzi A, Fazia ML. , et al. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol 2006; 26 (12) 2716-2723
    CrossrefPubMedSearch in Google Scholar
  • 74 Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001; 108 (07) 949-955
    CrossrefPubMedSearch in Google Scholar
  • 75 Zhang F, Kent KC, Yamanouchi D. , et al. Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm. Ann Surg 2009; 250 (03) 416-423
    CrossrefPubMedSearch in Google Scholar
  • 76 Hofmann Bowman M, Wilk J, Heydemann A. , et al. S100A12 mediates aortic wall remodeling and aortic aneurysm. Circ Res 2010; 106 (01) 145-154
    CrossrefPubMedSearch in Google Scholar
  • 77 Das D, Gawdzik J, Dellefave-Castillo L. , et al. S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications. J Am Coll Cardiol 2012; 60 (08) 775-785
    CrossrefPubMedSearch in Google Scholar
  • 78 Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5 (04) 331-342
    CrossrefPubMedSearch in Google Scholar
  • 79 Kohno T, Anzai T, Kaneko H. , et al. High-mobility group box 1 protein blockade suppresses development of abdominal aortic aneurysm. J Cardiol 2012; 59 (03) 299-306
    CrossrefPubMedSearch in Google Scholar
  • 80 Yamagishi S, Adachi H, Nakamura K. , et al. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects. Metabolism 2006; 55 (09) 1227-1231
    CrossrefPubMedSearch in Google Scholar